Orchestra BioMed Holdings, Inc. OBIO

Set alert

Price alert · OBIO

All alert types
5.77 USD +0.08 +1.41%

As of Nov 3, 11:35 AM ET

Bid
5.76 × 1
Ask
5.78 × 1
5.66 Day range 5.98
3.46 52-week range 6.50
YTD
+39.04%
1 year
+46.08%
Open
5.70
Prev close
5.69
Mkt cap
346.81M
Vol
24.28K
Avg vol
339.03K
EPS
-0.86
P/E
0.00
Div yield
0.00%
More statistics
Low
5.66
High
5.98
Forward P/E
-2.66
Beta
0.41
Short ratio
12.51
Inst. own
54.96%
Dividend
0.00
Ex-div date
Earnings
Aug 12, 2024
50-d avg
5.55
200-d avg
5.90
1y target
15.60

MAX chart

Chart tools
Interval

Events in this range
  • Mar 27, 2024Earnings: —; estimate -0.38; surprise —%
  • Mar 28, 2024Rating: Chardan Capital · Buy → Buy
  • May 13, 2024Earnings: —; estimate -0.4; surprise —%
  • May 13, 2024Earnings: -0.38; estimate -0.4; surprise 5%
  • Jun 12, 2024Rating: Chardan Capital · Buy → Buy
  • Jul 25, 2024Rating: B. Riley Securities · — → Buy
  • Aug 12, 2024Earnings: -0.45; estimate -0.41; surprise -9.76%
  • Aug 12, 2024Earnings: —; estimate -0.41; surprise —%
  • Aug 22, 2024Rating: HC Wainwright & Co. · — → Buy
  • Nov 12, 2024Earnings: -0.41; estimate -0.44; surprise 6.82%
  • Nov 13, 2024Rating: Chardan Capital · Buy → Buy
  • Nov 15, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (114)
NameDateAgo
SMA: BearishNov 2, 20261 day ago
SMA: BullishOct 26, 20261 week ago
SMA: BearishOct 12, 20263 weeks ago
RSI: OverboughtSep 7, 20261 month ago
MACD: Buy SignalAug 10, 20262 months ago
SMA: BullishAug 3, 20263 months ago
SMA: BullishJul 27, 20263 months ago
SMA: BearishJul 6, 20264 months ago
SMA: BearishJul 6, 20264 months ago
SMA: BullishJun 22, 20264 months ago
SMA: BullishJun 22, 20264 months ago
SMA: BearishJun 15, 20264 months ago
SMA: BullishJun 8, 20264 months ago
SMA: BearishApr 27, 20266 months ago
SMA: BearishApr 20, 20266 months ago
SMA: BullishApr 13, 20266 months ago
SMA: BearishApr 6, 20267 months ago
MACD: Sell SignalMar 23, 20267 months ago
MACD: Buy SignalMar 16, 20267 months ago
SMA: BullishFeb 23, 20268 months ago

Newest 20 of 114.

Analyst view

Price target (mean) 15.60 +170.4% upside
Target (low)
14.00
Target (mean)
15.60
Target (high)
20.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

OBIO analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.425-0.44 – -0.42-0.3209-32.4%829.60K+216.6%4
Next quarter-0.45667-0.48 – -0.42-0.38-20.2%830.25K+33.9%3
Current year-1.66-1.67 – -1.65-1.43-15.4%3.18M+15.2%4
Next year-1.95-2.09 – -1.72-1.66-17.5%3.84M+20.8%4

Upgrades and downgrades

The latest rating changes

OBIO analyst upgrades and downgrades
DateFirmActionFromTo
Nov 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 13, 2024Chardan CapitalMaintainedBuyBuy
Aug 22, 2024HC Wainwright & Co.Initiated—Buy
Jul 25, 2024B. Riley SecuritiesInitiated—Buy
Jun 12, 2024Chardan CapitalReiteratedBuyBuy
Mar 28, 2024Chardan CapitalMaintainedBuyBuy
Jan 19, 2024JefferiesInitiated—Buy
Aug 11, 2023Chardan CapitalReiteratedBuyBuy
Aug 9, 2023Chardan CapitalReiteratedBuyBuy
May 15, 2023Chardan CapitalReiteratedBuyBuy
Feb 24, 2023Piper SandlerInitiated—Overweight
Feb 7, 2023Chardan CapitalInitiated—Buy